Literature DB >> 9128205

The renin-angiotensin system and compensatory renal hypertrophy in the rat.

J P Valentin1, L A Sechi, C A Griffin, M H Humphreys, M Schambelan.   

Abstract

Angiotensin II (Ang II) may act as an angiogenic and growth promoting factor in different tissues. To assess the role of Ang II in compensatory renal growth following unilateral nephrectomy (UNX), we measured renin, angiotensinogen, and Ang II type 1 (AT1) receptor mRNA levels, as well as Ang II receptor density, in two groups of Sprague-Dawley rats 7 days after either sham operation or UNX. Half of each group received either no treatment or an angiotensin-converting enzyme inhibitor (100 mg/dL captopril in the drinking water, initiated at the time of the intervention). Following UNX, the ratio of kidney weight to body weight (KW/BW) in untreated animals was greater than in rats undergoing sham UNX (0.46 +/- 0.01 v 0.37 +/- 0.01%, P < .01). Neither renal renin, nor renal or hepatic angiotensinogen mRNA levels, determined by slot blot hybridization, changed significantly after UNX. Ang II receptor density in glomeruli, determined using an 125I-Sar1-Ile8 Ang II in situ receptor binding assay on frozen kidney sections, did not change significantly after UNX, nor did renal AT1 receptor mRNA. In captopril-treated rats, KW/BW was greater in UNX than in sham operated rats (0.44 +/- 0.01 v 0.37 +/- 0.01%, P < .01), similar to results in untreated animals. Renal and hepatic angiotensinogen mRNA levels were not affected by captopril treatment and did not change further in response to UNX. Captopril treatment increased renin mRNA in both sham operated and UNX rats as compared with untreated controls, but had no significant effect on Ang II receptor density and AT1 receptor mRNA; and no change was observed in either variable as a consequence of UNX. Thus, compensatory renal hypertrophy following UNX occurred in the absence of measurable changes in components of the renin-angiotensin system, and despite functionally significant inhibition of this system by captopril. These data do not support a critical role for Ang II in compensatory renal hypertrophy.

Entities:  

Mesh:

Year:  1997        PMID: 9128205

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  4 in total

1.  Effects of AT1 receptor antagonist, losartan, on rat hepatic fibrosis induced by CCl(4).

Authors:  Hong-Shan Wei; Ding-Guo Li; Han-Ming Lu; Yu-Tao Zhan; Zhi-Rong Wang; Xin Huang; Jing Zhang; Ji-Lin Cheng; Qin-Fang Xu
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

2.  Divergent roles of angiotensin II upon the immediate and sustained increases of renal blood flow following unilateral nephrectomy.

Authors:  Satoshi Shimada; Chun Yang; Theresa Kurth; Allen W Cowley
Journal:  Am J Physiol Renal Physiol       Date:  2022-02-28

3.  Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice.

Authors:  R J Fern; C M Yesko; B A Thornhill; H S Kim; O Smithies; R L Chevalier
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

4.  Angiotensin converting enzyme activity in compensatory renal hypertrophy.

Authors:  Nermina Babić; Jasminko Huskić; Emina Nakas-Ićindić
Journal:  Bosn J Basic Med Sci       Date:  2007-02       Impact factor: 3.363

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.